Media-OutReach Newswire Diabetes Association Unveils T-CaReMe Taipei Declaration at the Asia Diabetes International Conference
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Health2Sync Partners with Western Sydney Diabetes to Improve Glycemic Control through Digital Solutions